eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | fanconi anemia |
| Comorbidity | C0030312|bone marrow failure |
| Sentences | 7 |
| PubMedID- 22683204 | bone marrow failure in fanconi anemia is triggered by an exacerbated p53/p21 dna damage response that impairs hematopoietic stem and progenitor cells. |
| PubMedID- 24019220 | Oxandrolone for the treatment of bone marrow failure in fanconi anemia. |
| PubMedID- 24960628 | Hematopoietic cell transplantation (hct) can cure bone marrow failure in patients with fanconi anemia (fa), and it is generally accepted that these patients should receive low-intensity conditioning because of the underlying dna repair defect in their cells. |
| PubMedID- 23547077 | Purpose: allogeneic hematopoietic cell transplantation (hct) can cure bone marrow failure in patients with fanconi anemia (fa). |
| PubMedID- 25534205 | bone marrow failure in fanconi anemia (fa) has been linked in part to overproduction of inflammatory cytokines, to which fa stem and progenitor cells are hypersensitive. |
| PubMedID- 22178060 | Treatment of the bone marrow failure in fanconi anemia patients with danazol. |
| PubMedID- 23275558 | For example, fanconi anemia (fa) patients with an advanced bone marrow failure have almost no hematopoietic stem cells (hscs) in their hematopoietic tissues, precluding a classic hsc-based ex vivo gene therapy. |
Page: 1